Using standard inmunohistochemical methods, CYP3A4/CYP3A5 enzymes have been previously identified in various types of malignant tumors, including soft tissue sarcomas and osteosarcoma [29], [30]. This evidence concerns the gene CYP3A5 and soft tissue sarcoma.